NasdaqGS - Nasdaq Real Time Price USD

Akero Therapeutics, Inc. (AKRO)

55.62
+2.06
+(3.85%)
At close: June 13 at 4:00:02 PM EDT
54.65
-0.97
(-1.74%)
After hours: June 13 at 7:12:29 PM EDT
All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-262,631
-230,107
-145,367
-92,517
-79,681
Investing Cash Flow
-649,740
-109,708
-223,623
-63,825
42,280
Financing Cash Flow
474,439
445,846
353,316
255,632
602
End Cash Position
185,922
340,238
234,207
249,881
150,591
Interest Paid Supplemental Data
4,194
3,982
2,483
441
0
Capital Expenditure
--
-999
--
--
--
Issuance of Capital Stock
456,349
423,081
335,429
241,200
0
Issuance of Debt
0
10,000
15,000
10,000
0
Free Cash Flow
-263,630
-231,106
-145,367
-92,517
-79,681
12/31/2021 - 6/20/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ETNB 89bio, Inc.
10.41
+8.21%
 
MDGL Madrigal Pharmaceuticals, Inc.
295.57
-0.55%
 
SRRK Scholar Rock Holding Corporation
32.45
-2.61%
 
CYTK Cytokinetics, Incorporated
34.38
+3.55%
 
MLTX MoonLake Immunotherapeutics
44.21
+0.43%
 
PTGX Protagonist Therapeutics, Inc.
56.37
+0.09%
 
PCVX Vaxcyte, Inc.
34.56
+0.29%
 
BBIO BridgeBio Pharma, Inc.
39.78
+0.33%
 
CLDX Celldex Therapeutics, Inc.
21.26
+4.47%
 
KALV KalVista Pharmaceuticals, Inc.
12.96
-0.99%